GATA2 缺陷:对髓状细胞恶性和血造细胞移植的倾向
Roma V Rajput1, Danielle E Arnold2
1Hematology Branch, National Hematology, Lung, and Blood Institute, National Institute of Health, Bethesda, USA.
Current hematologic malignancy reports
|May 29, 2023
概括
GATA2 缺乏导致一系列健康问题,包括感染和骨髓细胞癌症. 全基性造血细胞移植 (HCT) 提供了治疗GATA2缺乏症的方法,具有高生存率和疾病逆转.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- GATA2缺乏症是一种遗传性疾病,症状可变,包括免疫缺陷和骨髓性恶性瘤的高风险.
- 大约75%的GATA2缺乏症患者会发展成骨髓瘤瘤.
- 全基性造血细胞移植 (HCT) 是目前唯一可用的治愈治疗方法.
研究的目的:
- 审查GATA2缺乏症的临床表现.
- 为了表征血液学异常和进展到骨髓质恶性瘤.
- 讨论当前的HCT实践和GATA2缺陷的结果.
主要方法:
- 在GATA2缺乏症中的临床表现和血液学异常的审查.
- 分析进展到骨髓性恶性瘤的情况.
- 评估当前的全源造血细胞移植 (HCT) 实践和结果.
主要成果:
- 细胞遗传异常,如三形8和单形7常见于与GATA2缺乏相关的骨髓质疏松综合征 (MDS).
- 在ASXL1和STAG2的体质突变是常见的,并与较差的生存率相关.
- 一项对59名患者的研究显示,在骨髓缩性全源性HCT后,总体 (85%) 和无事件 (82%) 存活率很好,疾病表型逆转和低移植对宿主疾病率.
结论:
- 具有骨髓衰变条件的异构HCT有效地纠正了GATA2缺乏症中的疾病表型.
- 对于患有严重感染,器官功能障碍,MDS,高风险突变或输血依赖症的患者,应考虑HCT.
- 需要进一步的研究来改善基因型/表型相关性,以便更好地预测疾病进展.
相关概念视频
Bone Marrow Sampling and Transplants
364
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
364
Glucose Transporters
23.6K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
23.6K
Translation
142.6K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
142.6K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


